Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Sep 09, 2026
Bitmine Immersion Technologies (BMNR): Can It Reach +49% to $37?

Bitmine Immersion Technologies (BMNR): Can It Reach +49% to $37?

Key Takeaways

  • Investors are asking whether Bitmine Immersion Technologies, Inc. (BMNR) can reach a $37 stock price target, a level roughly 49% above its most recent close near $24.77.
  • The strongest bullish case rests on the company's Ethereum (ETH) treasury, which exceeds 5.9 million tokens and is approaching its self-imposed "5% of supply" accumulation goal.
  • Analyst sentiment is positive, with a Strong Buy consensus and a 12-month average price target of about $31.87, versus a high estimate near $40.
  • The biggest risks include shareholder dilution, an eroding premium to net asset value (NAV), and heavy dependence on the volatile price of Ethereum.
  • Key technical markers include the $12.80 52-week low as major support and the $25–$26 zone as a near-term supply area, with the prior $65.60 high serving as long-term context.

Understanding BMNR's Focus on Ethereum Holdings

Bitmine Immersion Technologies, Inc. is a blockchain company chaired by Fundstrat co-founder Thomas "Tom" Lee. Rather than operating as a conventional bitcoin miner, BMNR has repositioned itself as an Ethereum treasury company that accumulates and stakes ETH while winding down proprietary self-mining. Its most recent disclosures put total holdings at roughly $15.7 billion, dominated by an Ethereum stack valued near $14.8 billion at a reference price of about $2,495 per token, alongside 211 Bitcoin, cash and marketable securities, and equity stakes in Beast Industries and Eightco Holdings (ORBS).

This structure matters for the price-target debate: BMNR's share price is largely a leveraged, sentiment-driven expression of Ethereum's performance, rather than the product of a diversified operating business. That cuts both ways when evaluating whether $37 is achievable. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Why the $37 Level Draws Attention

The $37 figure has circulated in public market commentary as a realistic "can it get there" question for BMNR, sitting above the analyst consensus but below the most bullish individual targets. From a price near $24.77, reaching $37 implies roughly a 49% advance — a meaningful but not implausible move for a high-beta digital-asset proxy that has repeatedly delivered double-digit weekly swings. It also represents a round, psychologically significant objective between the consensus target of $31.87 and the highest published estimate near $40.

Potential Drivers for Further Gains

The core catalyst is the Ethereum price itself. BMNR's chairman has publicly argued that ETH could approach $6,000, a scenario that would materially revalue the treasury and could push the stock well beyond $37. Because the company holds more than 5.9 million ETH, even a modest rise in the token price flows directly into the value of its balance sheet.

A second catalyst is the "Alchemy of 5%" milestone. Bitmine has disclosed that it holds roughly 4.9% of total Ethereum supply and needs only about 170,800 additional tokens to reach its stated 5% goal. Crossing that threshold could reinforce the company's strategic narrative and attract additional institutional attention.

Staking provides a third pillar. Approximately 85% of holdings are staked, generating a projected annualized revenue stream of about $330 million, with the figure rising as the company's institutional staking platform scales. This gives BMNR a recurring, cash-generating component beyond simple token appreciation. From what I see, these elements together shape the upside case.

Current Analyst Targets and Outlook

Coverage remains limited but constructive. Analysts at B. Riley and Cantor Fitzgerald have maintained Buy-equivalent ratings, with recent targets in the $25–$33 range, while the 12-month average across three analysts sits near $31.87. That consensus implies roughly 29% upside from current levels — meaning a move to $37 would require the stock to outrun the average Wall Street forecast and instead track the more aggressive end of the range.

Key Risks to Consider

The obstacles are substantial. First, BMNR trades with a high price-to-sales ratio and reports negative earnings, meaning the valuation is anchored to crypto sentiment rather than conventional fundamentals. Second, the company has authorized a dramatic expansion of its share count, and continued issuance could dilute per-share value even if the underlying treasury grows. Third, the stock has historically traded at a premium to NAV, and any further erosion of that premium would pressure the share price independent of Ethereum's direction.

Macro and regulatory risk also looms. Ethereum's price path remains tied to Bitcoin's performance, broader liquidity conditions, and the outcome of digital-asset legislation such as the CLARITY Act. A prolonged crypto downturn would directly undermine the $37 scenario.

Important Technical Levels

On a technical basis, $37 sits above the near-term consolidation range of roughly $18–$26. The $25–$26 area has repeatedly acted as a supply zone, and a sustained breakout above it would be a necessary first step toward higher targets. Below, the $12.80 52-week low marks the major support level and defines the downside risk profile. The 52-week high near $65.60 serves as a reminder of how quickly this stock can re-rate in either direction, but it also illustrates how far the shares have fallen from their peak.

Monitoring the Situation with AI Tools

Traders tracking volatile digital-asset names such as BMNR may benefit from tools that monitor changing conditions around the clock. I recently looked at Tickeron's AI Daily Buy/Sell Signals to help track shifts in momentum and support levels more systematically. These signals use artificial intelligence to continuously scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and AI-driven analysis. They are designed to help traders spot emerging opportunities, monitor existing positions, and identify shifting trends more efficiently. For investors seeking a systematic way to stay ahead of fast-moving price action, exploring AI Daily Buy/Sell Signals can offer an additional layer of market insight.

Overall Assessment

Can Bitmine Immersion Technologies reach $37? The path exists, but it is contingent rather than assured. A sustained Ethereum rally toward the levels its chairman has described, combined with the company completing its 5% accumulation target and preserving investor confidence despite ongoing dilution, would make $37 attainable. Against that, negative earnings, a leveraged premium to NAV, and the stock's sensitivity to crypto sentiment represent real obstacles.

Investors should monitor Ethereum's price trend, Bitmine's weekly treasury disclosures and share issuance, staking revenue growth, and any change in the stock's premium to NAV. These factors — more than any single technical indicator — will determine whether the $37 stock price target moves from speculation to reality. I'm watching this closely as developments unfold.

Exploring Tickeron AI Tools for Research

In my own analysis, I often turn to Tickeron's AI Daily Buy/Sell Signals to get a clearer view of momentum across volatile names like this one. The platform scans a wide range of securities in real time and delivers actionable signals that complement traditional research. It has become a practical part of how I track fast-changing sectors without adding unnecessary complexity to the process.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BMNR

BMNR's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for BMNR moved out of overbought territory on September 01, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 instances where the indicator moved out of the overbought zone. In 14 of the 14 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMNR as a result. In 116 of 128 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for BMNR turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 65 similar instances when the indicator turned negative. In 60 of the 65 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMNR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

BMNR broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 50-day moving average for BMNR moved above the 200-day moving average on September 29, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +10.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMNR advanced for three days, in 91 of 133 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

The Aroon Indicator entered an Uptrend today. In 79 of 103 cases where BMNR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. BMNR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.396) is normal, around the industry mean (4.351). P/E Ratio (2.332) is within average values for comparable stocks, (30.023). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. BMNR's P/S Ratio (133.333) is slightly higher than the industry average of (16.763).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMNR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 12.69B. The market cap for tickers in the group ranges from 590 to 304.12B. MS holds the highest valuation in this group at 304.12B. The lowest valued company is FSSLD at 590.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was 0%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 3%. XP experienced the highest price growth at 39%, while PMAX experienced the biggest fall at -35%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 12%. For the same stocks of the Industry, the average monthly volume growth was -6% and the average quarterly volume growth was -50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 63
Price Growth Rating: 59
SMR Rating: 74
Profit Risk Rating: 86
Seasonality Score: 24 (-100 ... +100)
View a ticker or compare two or three
BMNR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry InvestmentBanksBrokers

Industry
N/A
Address
10845 Griffith Peak
Phone
+1 404 816-8240
Employees
7
Web
https://www.bitminetech.io
Interact to see
Advertisement
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
I've always appreciated how Mastercard (MA) maintains a commanding position in the global payments industry, processing transactions across 3.4 billion cards at 150 million merchant locations worldwide. The network effects here create a formidable moat—increased adoption by issuers, acquirers, and consumers just reinforces its dominance. What stands out to me is how Mastercard is evolving beyond a pure processor into a services-first platform. Value-added services (VAS)—covering cybersecurity, data analytics, and consulting—are now approaching 40% of revenues and growing at double the rate of traditional payments.
MU shares are declining approximately -6.00% in premarket trading on April 2, 2026, pulling back to roughly $353.70 from the prior session's close of $376.27. The primary catalyst is a sweeping new round of tariff announcements from the Trump administration, dubbed by markets as "Liberation Day 2.0," which has sparked a broad risk-off selloff across technology and semiconductor stocks
Shares of Robinhood Markets are down approximately 6.15% in Thursday's intraday session, trading around $65.80 after closing at $70.11 on April 1, 2026. Wolfe Research delivered a sharp blow by cutting its price target on HOOD by 30%, citing persistent weakness in crypto trading volumes as a core drag on revenue.
Shares of Iridium Communications (IRDM) surged approximately +11.00% in Thursday's session, rising from a prior close of $28.52 to an intraday high near $31.76. A broad-based equity market rally drove significant gains across communication and satellite sector stocks, as investor sentiment sharply reversed after days of macro-driven selling pressure tied to tariff fears.
AirSculpt Technologies, Inc. (AIRS) stands out as a leading provider of minimally invasive body contouring procedures through its Elite Body Sculpture brand. The company specializes in proprietary AirSculpt treatments that remove fat and tighten skin without general anesthesia. These include options like AirSculpt+, AirSculpt Smooth for cellulite reduction, and specialized fat transfer procedures such as Power BBL for Brazilian butt lifts, Up a Cup for breast enhancement, and Hip Flip for hourglass contouring. Based in Miami Beach, Florida, and founded in 2012, AIRS operates centers across the United States, Canada, and the United Kingdom.
ASRT stock surged +66% over the past 30 days, driven by strong Q4 2025 earnings beat and optimistic 2026 guidance highlighting Rolvedon growth. Over the past quarter, the stock rose +117%, fueled by improving gross margins, stable product demand, and analyst price target increases.
I've been following Advantage Solutions Inc. (ADV)closely as a key player in outsourced sales, marketing, merchandising, sampling, and retailer support services for consumer packaged goods (CPG) manufacturers and retailers across North America, Asia Pacific, and Europe. The company operates through three segments: Branded Services, Experiential Services, and Retailer Services. Its focus remains on optimizing in-store execution, boosting consumer engagement, and strengthening retail partnerships.
NCS Multistage Holdings, Inc. (NCSM) stands out as a leading provider of highly engineered products and support services that optimize oil and natural gas well construction, completions, and field development strategies. The company operates primarily in the United States, Canada, and internationally, with a focus on fracturing systems, enhanced oil recovery, well construction products, and tracer diagnostics.
MGNX stock surged +53% over the last 30 days, driven primarily by a positive Q4 earnings surprise and analyst upgrades. Over the past quarter, the stock rose +80%, reflecting recovery from early-year lows amid biotech sector volatility.
PENG shares are surging approximately +16% in today's session, trading around $20.42, up from a prior close of $17.60 The primary catalyst is a Q2 fiscal 2026 earnings beat, with non-GAAP EPS of $0.52 surpassing the consensus estimate of $0.43 — a ~21% upside earnings surprise.